Cancer Genetics Inc. analyst estimates by MarketWatch. View CGIX revenue estimates and earnings estimates, as well as analyst recommendations. May 19, 2015 8:51AM EDT O ne stock that might be an intriguing choice for investors right now is Cancer Genetics, Inc. (CGIX). This is because this security in the medical services space is seeing Cancer Genetics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%. Investors interested in the medical services industry may also consider ICON plc (ICLR) which sports a Zacks TRIL Stock Forecast and Technical Analysis Buy or Hold candidate since 2020-05-01 Gain 66.45% PDF Trillium Therapeutics Inc. gained 9.65% in the last trading day (Monday, 8th Jun 2020), rising from $7.15 to $7.84 During the day the stock fluctuated 10.49% from a day low at $7.15 to a day high of $7.90 . View Cancer Genetics Inc CGIX investment & stock information. Get the latest Cancer Genetics Inc CGIX detailed stock quotes, stock data, Real-Time ECN,
May 28, 2020 Cancer Genetics Stock Chart - CGIX
Company Name: Cancer Genetics Inc., Stock Symbol: CGIX, Industry: Medical - Drugs, Total Posts: 881, Last Post: 5/18/2020 4:08:03 PM CGIX - Cancer Genetics Stock Barchart Opinion - Barchart.com Barchart Opinion & Trading Performance. Barchart Opinions add market-timing information by calculating and interpreting signal strength and direction. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods.
CGIX stock: Cancer Genetics Inc Current Rating. Strong Sell. Previous Rating. Strong Sell. Our Strong Buys double the S&P500! Learn more. Company Statistics. Price. $3.08. Market Cap. 6.1M Sector. Health Care. Div. Growth - P/E - P/B. 0.83 P/S. 0.51 Dividend % - P/CF. 2.4 P/FCF - Op. Cash Flow Get the latest Cancer Genetics Inc CGIX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Cancer Genetics, Inc. - CGIX - Stock Price Today - Zacks CGIX is up 23.84% today, Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. CGIX: Cancer Genetics Inc - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Cancer Genetics Inc from Zacks Investment Research
A-Agilent Technologies, Inc. Common Stock AA-Alcoa Corporation Common Stock AAAU-Perth Mint Physical Gold ETF AACG-ATA Creativity Global - American A reverse stock splits list, with links to full split history. CGIX Split History, 1 for 30, 10/25/2019 Direxion Zacks MLP High Income Index Shares (ZMLP). Listen to renowned small cap stock analyst Frank Curzio talk with leading President of a small-cap, clinical and diagnostics company - Cancer Genetics ( CGIX). at Belpointe Capital and Senior Equities Strategist at Zacks Investment Rese. Results 1 - 20 of 25 Pharma/Biotech Stocks to Watch This Prostate Cancer Month - September 14, 2018 - Zacks. . Cancer View the real-time CGIX price chart on Robinhood and decide if you want to buy or sell commission-free. All Stocks. 30 Apr 2013 This is why the stock market right now is at all-time highs. James once had a target price of $79 on Trovagene or CGIX is at 4.10 and my cost hung up on the extremevaluestocks great web site, zacks picks and cramer too.